ClinicalTrials.Veeva

Menu

IRIS- DESyne X2 in the IRIS-DES Registry (IRIS DESyne X2)

S

Seung-Jung Park

Status

Enrolling

Conditions

Coronary Disease
Coronary Occlusion
Coronary Stenosis

Treatments

Device: DESyne X2

Study type

Observational

Funder types

Other

Identifiers

NCT03588481
AMCCV2018-09

Details and patient eligibility

About

This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.

Enrollment

1,000 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 19 and more
  • Intervention with DeSyne X2 drug-eluting coronary stent
  • Agreed with written informed consent form

Exclusion criteria

  • Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
  • Life expectancy of 1year and under
  • Cardiac shock

Trial design

1,000 participants in 1 patient group

Coronary stenosis
Treatment:
Device: DESyne X2

Trial contacts and locations

6

Loading...

Central trial contact

Jung-hee Ham, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems